Impact of COVID-19 on children and adolescents with autism spectrum disorder (ASD) and their families

Impact of COVID-19 on children and adolescents with autism spectrum disorder (ASD) and their families - Autism & COVID-19

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54902

Enrollment

Registered

2020-11-20

Start date

2021-01-04

Completion date

Unknown

Last updated

2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autism spectrum disorder

Interventions

None listed

Eligibility

Age

12 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1) child is between the ages of 4 to 21 years old; 2) there is a clinical diagnosis of ASD; 3) there are measurements available pre-COVID-19 measures (either intake or ROM-data)

Exclusion criteria

Exclusion criteria: 1) parent and/or client do not master the Dutch language sufficiently to be able to participate 2) parent/client cannot or will not give informed consent for participation.

Design outcomes

Primary

Measure	Time frame
The primairy outcome variables are: - General functioning: o Child Behavior Checklist (CBCL): T0 vs. T1 vs. T2 o Youth Self Report (YSR): T0 vs. T1 - Autism characteristics: o Social Responsiveness Scale (SRS-2/SRS-A): T0 vs. T1 vs. T2 - Individual parent interviews to chart family functioning and (current) care- and informational needs.	—

Secondary

Measure	Time frame
- Quality of life of the child (PedSQL): T1 vs. T2 - Impact of COVID-19: e.g. behavior, stress, anxiety; atmosphere at home, effect on child: T1 vs. T2 - Parenting load (OBVL): T1 vs. T2	—

Countries

Netherlands

Outcome results